Both are expected to report results by mid-2026
] If youre currently using a compounded GLP-1 medication for weight loss, its essential to plan ahead
Low-T symptoms are maddeningly vague
For example, the generic, semaglutide, has three associated brand-names, Ozempic, Rybelsus, and Wegovy
According to a recent study published in The New England Journal of Medicine, limited access to GLP-1 receptor agonists for weight management has resulted in patients turning to direct-to-consumer (DTC) platforms
If you suspect you've experienced a side effect from Ozempic, you can report this through the MHRA Yellow Card scheme at yellowcard